Ideal timing for testing: Before starting your GLP-1 medication (baseline) 4-6 weeks after starting treatment After any dose increase Quarterly during stable dosing Immediately if warning symptoms appear People at higher risk for electrolyte problems include those over 65, anyone with kidney disease, heart failure patients, people taking diuretics, and anyone with persistent GI symptoms lasting beyond the first 8-12 weeks of treatment
Mller u dvno nie je len obyajn drogria je to zitok z nakupovania, ktor si vs zska hne pri vstupe
5-Amino-1MQ (5-Amino-1-methylquinolinium NNMT inhibitor) is a Small molecule (CHN, MW 174.2)
Average results are 15-20% of starting body weight over 6-12 months
However, it does not directly contribute to faster weight loss
Weight Loss and Management with Semaglutide With its promising results in weight loss and management, semaglutide serves as a valuable tool for patients battling obesity